updated 10/20/2004 1:51:41 PM ET 2004-10-20T17:51:41

More flu vaccine is expected to be available for millions of Americans in January, but that could be too late.

  1. Don't miss these Health stories
    1. Splash News
      More women opting for preventive mastectomy - but should they be?

      Rates of women who are opting for preventive mastectomies, such as Angeline Jolie, have increased by an estimated 50 percent in recent years, experts say. But many doctors are puzzled because the operation doesn't carry a 100 percent guarantee, it's major surgery -- and women have other options, from a once-a-day pill to careful monitoring.

    2. Larry Page's damaged vocal cords: Treatment comes with trade-offs
    3. Report questioning salt guidelines riles heart experts
    4. CDC: 2012 was deadliest year for West Nile in US
    5. What stresses moms most? Themselves, survey says

The flu season typically peaks in January or later. It takes two weeks for people to develop immunity after being vaccinated, which should be done in October or November, according to the Centers for Disease Control and Prevention.

So while the U.S. government is searching all over the world for more vaccine, it is unclear how helpful the extra doses will be if they don’t arrive until next year.

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Disease, said Wednesday he believes the additional shots will arrive in time to help.

The flu season likely will “peak at the end of the December, the beginning of January, but it goes well through February and sometimes into March,” he said on CBS’s “The Early Show.”

“So, any amount of doses that one can get, even as late as January, clearly will be very helpful, particularly if we have a very active flu year,” Fauci said.

Federal health officials said Tuesday that 2.6 million additional doses of flu vaccine will be available in January, far fewer than the 48 million lost to contamination at a British manufacturing plant.

“We’re waging a comprehensive and aggressive response,” Health and Human Services Secretary Tommy Thompson told a news conference. “We have good reason to be optimistic in our ability to deal with the flu season and protect the most vulnerable from its harsh effects.”

Enough medicine to treat 100 million
He said there was enough antiviral medicine available to treat 40 million people, shortening illness in people sick with the flu and preventing illness in healthy people.

Between vaccines and antiviral drugs, enough medicine will be available to treat 100 million people this flu season, Thompson said. Federal authorities have asked that healthy adults refrain from getting vaccinated to leave enough for those at greatest risk: the very young, the very old and people with chronic illnesses.

Test your IQSen. John Kerry, President Bush’s Democratic challenger, has said the administration failed to heed warnings about a potential shortage.

“If you can’t get flu vaccines to Americans, how are you going to protect them against bioterrorism? If you can’t get flu vaccines to Americans, what kind of health care program are you running?” Kerry said.

In Florida, Bush sought to ease Americans’ concerns. “I want to assure them that our government is doing everything possible to help older Americans and children get their shots despite the major manufacturing defect that caused this problem,” he said.

Chiron Corp. was expected to provide the United States with 46 million to 48 million doses of flu vaccine, nearly half the supply the government anticipated needing. But British regulators closed Chiron’s Liverpool facility because of contamination.

That left the United States with about 55 million doses from its second manufacturer, Aventis Pasteur. At a news conference Tuesday, Aventis Pasteur announced it could produce another 2.6 million doses.

The extra vaccine won’t be ready for distribution until January.

Meanwhile, officials are looking “throughout the world” for additional vaccine, said Lester Crawford, Food and Drug Administration acting commissioner.

Crawford said the FDA would give expedited review to flu vaccine produced by ID Biomedical of Canada. The expedited review — “weeks, rather than months” — means the 1.5 million Canadian flu shots could reach Americans this season, he said. The agency plans to send its own inspectors to ensure the Canadian facilities meet U.S. manufacturing standards.

“We have similar standards,” said Jirina Vlk, a Health Canada spokeswoman. She said she expected the FDA to have the Health Canada records by the end of October.

© 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Discuss:

Discussion comments

,

Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Advertisement